- Home
- WVVI vs CVKD Comparison
WVVI vs CVKD Comparison
Compare WVVI & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVVI
- CVKD
- Stock Information
- Founded
- WVVI 1983
- CVKD 2022
- Country
- WVVI United States
- CVKD United States
- Employees
- WVVI N/A
- CVKD N/A
- Industry
- WVVI Beverages (Production/Distribution)
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- WVVI Consumer Staples
- CVKD Health Care
- Exchange
- WVVI Nasdaq
- CVKD Nasdaq
- Market Cap
- WVVI 28.2M
- CVKD 29.5M
- IPO Year
- WVVI N/A
- CVKD 2023
- Fundamental
- Price
- WVVI $5.53
- CVKD $13.06
- Analyst Decision
- WVVI
- CVKD Strong Buy
- Analyst Count
- WVVI 0
- CVKD 1
- Target Price
- WVVI N/A
- CVKD $32.00
- AVG Volume (30 Days)
- WVVI 24.7K
- CVKD 33.5K
- Earning Date
- WVVI 08-12-2025
- CVKD 08-06-2025
- Dividend Yield
- WVVI N/A
- CVKD N/A
- EPS Growth
- WVVI N/A
- CVKD N/A
- EPS
- WVVI N/A
- CVKD N/A
- Revenue
- WVVI $38,520,945.00
- CVKD N/A
- Revenue This Year
- WVVI N/A
- CVKD N/A
- Revenue Next Year
- WVVI N/A
- CVKD N/A
- P/E Ratio
- WVVI N/A
- CVKD N/A
- Revenue Growth
- WVVI N/A
- CVKD N/A
- 52 Week Low
- WVVI $3.17
- CVKD $5.70
- 52 Week High
- WVVI $7.18
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- WVVI 48.00
- CVKD 49.88
- Support Level
- WVVI $5.50
- CVKD $11.00
- Resistance Level
- WVVI $5.86
- CVKD $13.56
- Average True Range (ATR)
- WVVI 0.52
- CVKD 1.11
- MACD
- WVVI 0.04
- CVKD 0.23
- Stochastic Oscillator
- WVVI 38.43
- CVKD 80.67
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.